NCT03321318 - AK-R215 Pharmacokinetic Study Phase I | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 13, 2017

Primary Completion Date

September 18, 2017

Study Completion Date

January 12, 2018

Conditions

Healthy

Interventions

DRUG

AK-R215

Investigational product is prescribed to all ofrandomized subjects

DRUG

Bazedoxifene 20 mg

Investigational product is prescribed to all of randomized subjects

DRUG

Cholecalciferol 800IU

Investigational product is prescribed to all of randomized subjects

Trial Locations (1)

Dong-A University Hospital, Busan